March 26, 2020
Akcea Therapeutics is driven by determination and focus on addressing the unmet needs and complex medical challenges of patients with serious and rare disorders. As an established global development and commercial company currently seeking to expand their commercial and development pipelines, Akcea has retained The Chase Group to identify a Senior Vice President, Global Medical Affairs. The seasoned medical affairs executive will join the senior management team and be responsible for developing and evolving the global medical affairs strategy at Akcea while providing strategic and functional oversight and leadership to the strong and experienced team of global medical affairs personnel. The Chase Group is proud to partner with Akcea to secure a leader who will play an integral part in the decision-making and be a part of defining the direction of the company. For more information, please email karen@chasegroup.com.
